Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model.
about
Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Long-term treatment with EGFR ...... n Alport syndrome mouse model.
@en
Long-term treatment with EGFR ...... n Alport syndrome mouse model.
@nl
type
label
Long-term treatment with EGFR ...... n Alport syndrome mouse model.
@en
Long-term treatment with EGFR ...... n Alport syndrome mouse model.
@nl
prefLabel
Long-term treatment with EGFR ...... n Alport syndrome mouse model.
@en
Long-term treatment with EGFR ...... n Alport syndrome mouse model.
@nl
P2093
P2860
P1476
Long-term treatment with EGFR ...... in Alport syndrome mouse model
@en
P2093
Hirofumi Kai
Mary Ann Suico
Misato Kamura
Rui Miyakita
Ryosuke Fukuda
Tsubasa Yokota
Tsuyoshi Shuto
Yukari Kai
P2860
P2888
P304
P356
10.1007/S10157-017-1386-9
P50
P577
2017-02-08T00:00:00Z